Navidea Biopharmaceuticals, Inc. (NYSEMKT:NAVB)

CAPS Rating: 2 out of 5

Recs

0
Player Avatar SamsaricSufferer (< 20) Submitted: 7/4/2012 8:14:51 PM : Outperform Start Price: $4.26 NAVB Score: -63.43

PDUFA coming up

Featured Broker Partners


Advertisement